S&P 500

5.648,43

0,31%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Allos Therapeutics, Inc. (MM) (ALTH)
Allos Therapeutics, Inc. (MM) (ALTH) Notícias

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ALTH

<< Anterior 1 2 3 4 5 6 7 8 9 10 11 12 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
20/07/2011	11:37	Business Wire	Kendall Law Group Investigates Allos Therapeutics, Inc.	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	09:01	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	08:54	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/07/2011	08:00	Business Wire	AMAG Pharmaceuticals and Allos Therapeutics Agree to Merge to Strengthen Commercial Portfolio and Achieve Cost Synergies	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
13/07/2011	17:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/06/2011	10:30	Zacks	Label Expansion for CELG's Istodax - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/06/2011	18:29	Business Wire	Data Shows Activity of FOLOTYN® in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Following Treatment with ...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/06/2011	10:00	Marketwired	Research Report on Allos Therapeutics, Inc. and Spectrum Pharmaceuticals, Inc. -- BioPharm Looks Forward for Growth	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/06/2011	07:50	GlobeNewswire Inc.	Allos Therapeutics is MicroStockProfit.com's Biopharm Feature Stock	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/06/2011	03:30	Business Wire	Data Suggests Treatment with FOLOTYN® Reverses Trend of Progressive Resistance Observed in Patients with Drug-Resistant Rela...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
16/06/2011	03:30	Business Wire	COMPLETE Registry Provides First Glance into Treatment Patterns for Patients with Peripheral T-Cell Lymphoma	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
08/06/2011	10:00	Business Wire	FOLOTYN® Data to be Presented at the Congress of the European Hematology Association & the International Conference on Malig...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/06/2011	16:57	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/05/2011	13:49	Zacks	Risk-Reward Balanced at Allos - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
13/05/2011	13:55	Zacks	1Q Loss Narrows at Allos - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
10/05/2011	18:24	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
10/05/2011	17:05	Business Wire	Allos Therapeutics and Mundipharma Announce Strategic Collaboration for FOLOTYN	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
10/05/2011	17:00	Business Wire	Allos Therapeutics Reports First Quarter 2011 Financial Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/05/2011	15:42	Zacks	Mixed Results for CELG's Revlimid - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
04/05/2011	09:00	Business Wire	Allos Therapeutics to Present at Upcoming Investor Conferences in May	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/05/2011	09:00	Business Wire	Allos Therapeutics to Report First Quarter 2011 Results on May 10, 2011	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
02/05/2011	09:16	Marketwired	Oncology Drug Makers Positioned for Long Term Growth	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
29/04/2011	13:35	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
29/04/2011	13:31	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/04/2011	14:01	Zacks	Allos Therapeutics at Neutral - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
04/04/2011	12:20	Zacks	Cancer Study to Continue at SPPI - Analyst Blog	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
30/03/2011	09:00	Business Wire	Allos Therapeutics to Present at Upcoming Investor Conferences	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/03/2011	08:35	Marketwired	Speculative Biotech Firms Remain Popular Takeover Targets	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/03/2011	18:20	Edgar (US Regulatory)	Annual Report (10-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
03/03/2011	18:00	Business Wire	Allos Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 Trial of FOLOTYN in Patients with Pre...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)